Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Kidney Failure 100%
• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Congestive Heart Failure 100%
• Clinical Trial 33%
• Clinical Study 33%
• Sodium Glucose Cotransporter 33%
• Cardiovascular Risk 33%
• Cardiovascular Disease 33%
• Non Insulin Dependent Diabetes Mellitus 33%

Medicine and Dentistry

• Chronic Kidney Disease 100%
• Congestive Heart Failure 100%
• Cardiovascular Disease 33%
• Maturity Onset Diabetes of the Young 33%
• Cardiovascular System 33%
• Clinical Study 33%
• Clinical Trial 33%
• Cardiovascular Risk 33%